Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.
Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies.
pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
JC Virus Replication at the First Symptoms of Multiple Sclerosis: A Case Report.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Inherited and acquired disorders of myelin: The underlying myelin pathology.
Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
The human JC polyomavirus (JCPyV): virological background and clinical implications.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.
Pages
« first
‹ previous
…
390
391
392
393
394
395
396
397
398
…
next ›
last »